Management of Atrial Fibrillation With Flecainide : the AFFLEC Study

Atrial Fibrillation Clinical Trial

Official title:

Multicentre Non Interventional Study in the Management of Atrial Fibrillation With Flecainide

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02190175
• Other study ID #: AFFLEC
• Status: Completed
• Start date: June 2014
• Est. completion date: December 2015

Study information

• Verified date: March 2017
• Source: Hellenic Cardiovascular Research Society
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This is a multicentre non interventional observational study with the objective to follow up patients with atrial fibrillation who based on current indications are treated with per os flecainide , for cardiac pulse maintenance.

Description:

the study objectives are

• record safety and efficiency of flecainide as antiarrythmic treatment in atrial fibrillation

• study of flecainide in ST interval

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: December 2015
• Est. primary completion date: November 2015
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• patients with history of atrial fibrillation

• patients able to give informed consent

Exclusion Criteria:

• patients with coronary disease or other cardiopathy with left heart champer affected

Related Conditions & MeSH terms

• Atrial Fibrillation

Locations

Country	Name	City	State
Greece	Erythros Stavros Hospital	Athens
Greece	University Hospital of Larisa	Larisa
Greece	AHEPA University Hospital	Thessaloniki

Sponsors (1)

Lead Sponsor	Collaborator
Hellenic Cardiovascular Research Society

Country where clinical trial is conducted

Greece, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	ST interval and repolarization measures of myocardia in patients under treatment of flecainide		6months